Avricore Health Inc. announced it has signed a partnership agreement with Ellerca Health Corp. to utilize their respective technologies and services to offer the most robust diabetes screening and management solutions on the market for community pharmacy. Avricore Health’s Objective is to make actionable health information more accessible for everyone by creating the rapid testing network in pharmacy through HealthTab, its turnkey point-of-care testing solution that effectively turns pharmacies into diagnostic hubs (sometimes known as ‘Community Diagnostic Centres’ or CDCs) and connects them on a single, cloud-based platform. Ellerca Health Corp’s mission is to improve patient care through leading technologies and innovation. Through self-management of chronic diseases due to a fully supportive digital program, Ellerca Health allows patients to be in control of their own treatment through their 360Care™ app. Working together with patients in this way reduces the cost and time of reactionary treatment and shifts the focus to preventative care by reducing and eradicating symptoms of chronic conditions. Ellerca Health’s 360Care™ is an app-based digital platform for chronic disease management which is quickly growing its client base of benefits providers and drug makers to support better patient health outcomes. Through mutual collaboration on a project-by-project basis, the companies are committed to achieving their shared vision of bringing technologies to community settings which prioritize early-detection and screening, along with consistent management of chronic diseases, like diabetes. The companies look forward to jointly pursuing efforts to bring enhanced patient services in community pharmacy which utilize HealthTab™’s unique diagnostics and data-management systems with the ongoing coaching and support of 360Care™.